|

JS212 for Injection Clinical Trials

3 actively recruiting trials

▲ +2 trials since May 2026

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Shanghai Junshi Bioscience Co., Ltd.3

Indications

  • Cancer3
  • Advanced Malignant Solid Tumours1
  • Advanced Lung Cancer1
  • Advanced Malignant Solid Tumors1
  • Lung Cancer1

Other3 trials

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
Phase 1/2
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Phase 2
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.